Meningococcal B vaccine: JCVI position statement

JCVI position statement on the use of meningococcal B (MenB) vaccine in the UK.



The Joint Committee on Vaccination and Immunisation (JCVI) position statement includes a recommendation to offer the Bexsero MenB vaccine to children at 2, 4 and 12 months. This recommendation depends on securing a cost effective price for the Bexsero vaccine.

The JCVI position statement sets out the results of the considerations of JCVI and its meningococcal sub-committee on the use of meningococcal B vaccine, Bexsero in the UK.

Published 21 March 2014